Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walker

Showing results (551-560 of 568) with videos related to

Pageof 57
Sort By:
Lancet (London, England)|December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Health Technology Assessment (Winchester, England)|August 3, 2019
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCTMatthew Scarborough, Ho Kwong Li, Ines Rombach, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Journal of Pediatric Surgery|November 2, 2020
Clinical outcomes following implementation of a management bundle for esophageal atresia with distal tracheoesophageal fistulaChristina M Bence, Beth Rymeski, Samir Gadepalli, et al.
Hepatology Communications|April 1, 2026
The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensusAvik Majumdar, Jacinta Holmes, Stuart K Roberts, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2021
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination StatusSheila F Lumley, Gillian Rodger, Bede Constantinides, et al.
JCI Insight|November 25, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trialMeggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Pageof 57

Showing results (551-560 of 568) with videos related to

Sort By:
Pageof 57
Lancet (London, England)|December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Health Technology Assessment (Winchester, England)|August 3, 2019
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCTMatthew Scarborough, Ho Kwong Li, Ines Rombach, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Journal of Pediatric Surgery|November 2, 2020
Clinical outcomes following implementation of a management bundle for esophageal atresia with distal tracheoesophageal fistulaChristina M Bence, Beth Rymeski, Samir Gadepalli, et al.
Hepatology Communications|April 1, 2026
The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensusAvik Majumdar, Jacinta Holmes, Stuart K Roberts, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2021
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination StatusSheila F Lumley, Gillian Rodger, Bede Constantinides, et al.
JCI Insight|November 25, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trialMeggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Pageof 57